Trinity Biotech (TRIB) Work In Process (2016 - 2025)

Trinity Biotech's (TRIB) quarterly Work In Process came in at $3.7 million in Q4 2025, down 25.08% year-on-year from $5.0 million in Q4 2024, and down 25.08% quarter-over-quarter from $5.0 million in Q4 2024.

Trinity Biotech (TRIB) Work In Process (2016 - 2025) Analysis & Trends

Trinity Biotech has disclosed Work In Process across 7 years of filings, most recently posting $3.7 million for Q4 2025.

  • Work In Process for Q4 2025 came in at $3.7 million, down 25.08% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.7 million (down 25.08% YoY), and the FY2025 annual result was $3.7 million, down 25.08% from the prior year.
  • Work In Process came in at $3.7 million for Q4 2025 at Trinity Biotech, down from $5.0 million in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $5.0 million in Q4 2024 to a low of $3.7 million in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Trinity Biotech 23,520.00 -5.11 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 3.74 Mn
Dec 31, 2024 4.99 Mn
Dec 31, 2020 5.17 Mn
Dec 31, 2019 6.94 Mn
Dec 31, 2018 8.24 Mn
Dec 31, 2017 7.24 Mn
Dec 31, 2016 7.29 Mn